DURECT Corp (NASDAQ:DRRX)
| 0.83 Data as of 2:59pm ET |  -0.002 / -0.24%Today’s Change | 0.61 Today|||52-Week Range 1.85 | -9.78% Year-to-Date |
Latest DRRX News | Press Releases
No recent news for DURECT Corp.
Today’s Trading
| Previous close | 0.83 |
| Today’s open | 0.83 |
| Day’s range | 0.82 - 0.84 |
| Volume | 156,952 |
| Average volume (3 months) | 638,633 |
| Market cap | $84.8M |
| Dividend yield | -- |
Data as of 2:59pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -158.33% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +58.48% |
| P/E ratio | NM |
| Price/Sales | 1.53 |
| Price/Book | 2.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OGENOragenics Inc | +0.12 | +3.86% |
| IMMYImprimis Pharmaceuti... | -0.24 | -2.54% |
| PRANPrana Biotechnology ... | 0.00 | 0.00% |
| ANTHAnthera Pharmaceutic... | -0.01 | -2.08% |
Data as of 2:59pm ET, 06/19/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $53.1M |
| Annual profit (last year) | $16.2M |
| Net profit margin | 30.53% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Scientific Officer Felix Theeuwes, DSc |
President, Chief Executive Officer & Director James E. Brown, MD |
Corporate headquarters Cupertino, California |
Forecasts
